SLC22A2 and type 2 diabetes mellitus: The genetic variability of OCT2 gene SLC22A2 can play a crucial role in determining the pharmacokinetics and pharmacodynamics of metformin, influencing both its therapeutic efficacy and the risk of adverse effects in individuals with T2DM.